NeoGenomics Inc. Common Stock vs Pacific Gas & Electric Co. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Pacific Gas & Electric Co. Common Stock trades at $13.2 (market cap $40.02B). The key difference: Pacific Gas & Electric Co. Common Stock is far larger — about 18.7× NeoGenomics Inc. Common Stock's market cap, and Pacific Gas & Electric Co. Common Stock pays a 1.5% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Pacific Gas & Electric Co. Common Stock for 6 Days on average.
| NEO | PCG | |
|---|---|---|
Market Cap | $2.14B | $40.02B |
Volume | 2,228,400 | 38,222,102 |
Sector | Health | Utilities |
52-Week High | $19.91 | $19.11 |
52-Week Low | $7.19 | $11.95 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.44B | $105.33B |
Dividend Yield | — | 1.5% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PCG trades at $13.33, up 1.29% with a bullish technical signal despite mixed momentum indicators. The stock shows strong fundamentals with a P/E of 9.59 and net income margin of 12.25%, supported by recent earnings beats. Recent news highlights PG&E's proactive wildfire safety measures and strategic initiatives, including a 10-year undergrounding plan to mitigate risks. Analyst consensus remains positive with a $18.22 price target, though technical indicators show some overbought conditions.
PCG presents a value opportunity with attractive valuation metrics and improving profitability, but faces significant wildfire-related risks and regulatory uncertainty. The stock's upside potential depends on successful execution of safety initiatives and favorable regulatory outcomes, making it suitable for risk-tolerant investors seeking utility exposure with growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →PG&E Corporation is the parent company of Pacific Gas and Electric Company, a utility serving Northern and Central California. Its main business is the sale and delivery of electricity and natural gas.
Read more on PCG →